NIFTY
-91.80  -0.92%
 9872.60
S&P BSE SENSEX
-295.81  -0.93%
 31626.63
Cadila Healthcare Ltd.
NSE : CADILAHC BSE : 532321 ISIN code : INE010B01027
on 25-Sep-2017
NSE
-7.15    -1.46%
Rs. 481.95
 
Days Low
Rs. 472
Days High
Rs. 499

Open Rs. 494.8
 
52 week Low
Rs. 329.95
52 week High
Rs.558
 
 
Bid :                 0.00 (0)
Offer :        481.55 (35)
BSE
Rs.481.55
-7.6    -1.55%
on 25-Sep-2017
BSE
-7.6    -1.55%
Rs. 481.55
 
Days Low
Rs. 471.2
Days High
Rs. 497.9

Open Rs. 494.95
 
52 week Low
Rs. 328.8
52 week High
Rs.560
 
 
Bid :                 0.00 (0)
Offer :        481.55 (35)
NSE
Rs.481.95
-7.15    -1.46%
 
 
Last Price (Rs.)  481.55 Value  78797914.00
Net Change (Rs.)  -7.60 Best Buy  0.00
Volume  163122 Best Sell  481.55
Prev.Close (Rs.)  489.15 Best Quantity  0
Open (Rs.)  494.80 Sell Quantity  35
High (Rs.)  499.00 52-Week High (Rs.)  558.00
Low (Rs.)  472.00 52-Week Low (Rs.)  329.95
Face Value (Rs.)  1 Market Cap.(Rs/ Mn)  492983.25
 
BSE
You need to upgrade your Flash Player
 
Financial (Rs .in Million)
Balance Sheet
Share Capital1024.00 1024.00 1024.00 
Share Capital1024.00 1024.00 1024.00 
Share Capital1024.00 1024.00 1024.00 
Share Capital1024.00 1024.00 1024.00 
Share Capital1024.00 1024.00 1024.00 
Currents Investments0.00 1009.00 4583.00 
More> 
 
Top 5 PeerCompanies * (Rs .in Million)
Company NameLTP* M.CapBVP/EDiv.Yield
Sun Pharma Inds. 505.90 1213809 81.60 0.00 0.69
Piramal Enterprises 2704.85 466757 838.20 60.08 0.78
Cipla 576.90 464223 161.56 47.60 0.35
Lupin 991.30 447867 331.14 14.25 0.76
Aurobindo Pharma 702.55 411612 149.24 24.12 0.36
 
Mutual Funds Holdings
 
Quarterly Result
(Rs .in millions)Jun 2017Mar 2017Dec 2016
Net Sales10554.008285.0011011.00
Operating Profit2504.004693.001369.00
PBDT2385.004693.001332.00
Net Profit914.004714.00539.00
More> 
 
Company News
9/25/2017 12:00:00 AM
Zydus Cadila, Oberoi Realty and Artefact Projects to see some action t...
9/25/2017 12:00:00 AM
Zydus receives final approval from USFDA for Amlodipine, Olmesartan Me...
9/22/2017 12:00:00 AM
KNR Constructions, Zydus Cadila and Dabur India to see some action tod...
More>
 
Ratios
   Earnings Per Share (Rs)6.46 
   Book NAV/Share(Rs)64.63 
   PAT Margin (%)20.21 
   Asset Turnover(x)0.30 
   PER(x)68.57 
   Yield(%)0.72 
   EV/Core EBITDA(x)52.51 
   M Cap / Sales14.05 
   Net Sales Growth(%)-54.06 
   PAT Growth(%)-67.51 
   Total Debt/Equity(x)0.44 
   Current Ratio(x)0.71 
   Quick Ratio(x)0.40 
   Total Debt/Mcap(x)0.06 
More>